Natriumbicarbonaat Viaflo Baxter (Sodium Hydrogen Carbonate)

Sodium Hydrogen Carbonate, the active ingredient in Natriumbicarbonaat Viaflo Baxter, is an excipient presented as an injectable solution for intravenous use. It supplies bicarbonate ions that help buffer systemic pH, facilitating rapid correction of acid‑base imbalances in acute care settings such as metabolic acidosis, cardiac arrest, and certain drug overdoses.

GNH USA supplies Natriumbicarbonaat Viaflo Baxter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide, with the product sourced from the European Union market, and adhering to stringent quality standards.

Sodium Hydrogen Carbonate injection is used to address acid‑base disturbances and related emergency conditions. - Metabolic acidosis: restores systemic pH by increasing bicarbonate concentration. - Cardiac arrest with hyperkalemia: transiently raises serum pH to counteract potassium effects. - Drug overdose (e.g., tricyclic antidepressants): alkalinizes urine to enhance drug elimination. - Severe renal tubular acidosis: supports bicarbonate balance when endogenous production is insufficient. - Acute cyanide poisoning (as part of a protocol): provides cyanide binding capacity via conversion to thiocyanate.

Adverse reactions may occur following intravenous administration of sodium hydrogen carbonate.

Common Side Effects: - Injection site pain: mild discomfort at the infusion site. - Hypernatremia: elevated serum sodium levels. - Metabolic alkalosis: excessive rise in blood pH. - Hypokalemia: reduced serum potassium concentration.

Serious or Rare Side Effects: - Severe alkalosis: can lead to respiratory depression. - Pulmonary edema: fluid accumulation in lungs. - Cardiac arrhythmias: irregular heart rhythms due to electrolyte shifts. - Anaphylactic reaction: rare but potentially life‑threatening hypersensitivity.

When using sodium hydrogen carbonate injection, consider the following safety measures. - Renal impairment: monitor serum electrolytes and acid‑base status. - Cardiac disease: avoid rapid large bolus in patients with coronary artery disease. - Respiratory disorders: use cautiously in patients with COPD. - Pregnancy: limited data, weigh benefits versus potential risks. - Store at ambient temperature: keep in original container, protect from moisture and light.

Sodium hydrogen carbonate may interact with several medications; awareness of these interactions helps maintain patient safety.

Major Interactions (Avoid): - Aminoglycosides: increased risk of nephrotoxicity due to altered urinary pH. - Calcium channel blockers: reduced efficacy in overdose treatment protocols. - Loop diuretics: may exacerbate electrolyte disturbances.

Moderate Interactions (Monitor Closely): - Potassium supplements: risk of hypokalemia when bicarbonate shifts potassium intracellularly. - ACE inhibitors: monitor for shifts in acid‑base balance. - Insulin therapy: altered glucose control due to pH changes.